Nascent Biotech Inc.: Nascent Begins Enrollment of Final Patient Cohort to Complete Phase One Clinical Research

VERO BEACH, FL / ACCESSWIRE / October 4, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company focused on the development of

Related Keywords

Sean Carrick ,Exchange Commission ,Nascent Biotech Inc ,Securities Exchange ,Nascent Biotech Inc Form ,Nascent Biotech ,Metastatic Brain ,Fifth Cohort ,Securities Act ,Securities Exchange Act ,Private Litigation Reform Act ,Nascent ,Biotech ,Egins ,Enrollment ,Final ,Patient ,Cohort ,Omplete ,Hase ,Linical ,Research ,